01 9Gowling WLG (Canada) LLP
01 12232191
02 12620380
03 12631646
04 12667654
05 12709997
06 12710014
07 12710358
08 12762013
09 12819967
01 9Pirfenidone
01 9Capsules
01 12016-09-17
02 22026-09-22
03 12026-11-29
04 12027-12-18
05 12029-11-09
06 22030-08-17
07 12033-07-04
Patent Expiration Date : 2026-09-22
Date Granted : 2012-10-30
Brand Name : ESBRIET
Patent Number : 2620380
Filing Date : 2006-09-22
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2012-10-30
Patent Expiration Date : 2016-09-17
Date Granted : 2011-03-15
Brand Name : ESBRIET
Patent Number : 2232191
Filing Date : 1996-09-17
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-09-17
Date Granted : 2011-03-15
Patent Expiration Date : 2029-11-09
Date Granted : 2012-03-27
Brand Name : ESBRIET
Patent Number : 2709997
Filing Date : 2009-11-09
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2029-11-09
Date Granted : 2012-03-27
Patent Expiration Date : 2026-09-22
Date Granted : 2014-07-08
Brand Name : ESBRIET
Patent Number : 2762013
Filing Date : 2006-09-22
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-07-08
Patent Expiration Date : 2033-07-04
Date Granted : 2016-03-22
Brand Name : ESBRIET
Patent Number : 2819967
Filing Date : 2013-07-04
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2033-07-04
Date Granted : 2016-03-22
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Brand Name : ESBRIET
Patent Number : 2710014
Filing Date : 2010-08-17
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Brand Name : ESBRIET
Patent Number : 2710358
Filing Date : 2010-08-17
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Patent Expiration Date : 2026-11-29
Date Granted : 2016-07-26
Brand Name : ESBRIET
Patent Number : 2631646
Filing Date : 2006-11-29
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-11-29
Date Granted : 2016-07-26
Patent Expiration Date : 2027-12-18
Date Granted : 2016-12-13
Brand Name : ESBRIET
Patent Number : 2667654
Filing Date : 2007-12-18
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-12-18
Date Granted : 2016-12-13
